EIF2A anticorps

N° du produit ABIN966051

Détail du produit anti-EIF2A anticorps

Antigène: EIF2A (Eukaryotic Translation Initiation Factor 2A, 65kDa (EIF2A))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp EIF2A est non-conjugé

Application: Immunohistochemistry (IHC)

Specificité: EIF2 (Ab-51) antibody detects endogenous levels of total eIF2 protein.

Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Immunogène: The antiserum was produced against synthesized non-phosphopeptide derived from human eIF2 around the phosphorylation site of serine 51 (E-L-SP-R-R).

Information d'application

Indications d'application: WB: 1:500~1:1000
IHC: 1:50~1:100.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 100ug/100ul.

Buffer: Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 50% glycerol

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Références pour anticorps anti-EIF2A (ABIN966051)

Kubota, Obata, Ota, Sasaki, Ito: "Rapamycin-induced translational derepression of GCN4 mRNA involves a novel mechanism for activation of the eIF2 alpha kinase GCN2." dans: The Journal of biological chemistry, Vol. 278, Issue 23, pp. 20457-60, (2003) (PubMed).

Saelens, Kalai, Vandenabeele: "Translation inhibition in apoptosis: caspase-dependent PKR activation and eIF2-alpha phosphorylation." dans: The Journal of biological chemistry, Vol. 276, Issue 45, pp. 41620-8, (2001) (PubMed).

Détails sur EIF2A

Antigène: EIF2A (Eukaryotic Translation Initiation Factor 2A, 65kDa (EIF2A))

Autre désignation: eIF2alpha (EIF2A Produits)

Synonymes: anticorps ATEIF2-A2, anticorps EIF2-A2, anticorps eukaryotic translation initiation factor 2 alpha subunit, anticorps EIF-2A, anticorps MST089, anticorps MSTP004, anticorps MSTP089, anticorps D030048D22, anticorps D3Ertd194e, anticorps im:7145971, anticorps zgc:110460, anticorps DDBDRAFT_0185936, anticorps DDBDRAFT_0234177, anticorps DDB_0185936, anticorps DDB_0234177, anticorps Eif2a, anticorps eif2a, anticorps eif2alpha, anticorps EIF2A, anticorps CG9946, anticorps Dmel\\CG9946, anticorps Eif2alpha, anticorps IF2A_DROME, anticorps M(1)14C, anticorps M(1)19-153, anticorps M(1)8e3-10, anticorps deIF2alpha, anticorps eIF-2, anticorps eIF-2 a, anticorps eIF-2 alpha, anticorps eIF2 alpha, anticorps eIF2-alpha, anticorps eIF2a, anticorps eIF2alpha, anticorps eiF-2alpha, anticorps elF2alpha, anticorps l(1)14Cf, anticorps l(1)19-153, anticorps eukaryotic translation initiation factor 2 alpha subunit, anticorps eukaryotic translation initiation factor 2A, anticorps eukaryotic translation initiation factor 2A, 65kDa, anticorps eukaryotic translation initiation factor 2A S homeolog, anticorps eukaryotic translation initiation factor, anticorps eukaryotic translation Initiation Factor 2alpha, anticorps EIF2 ALPHA, anticorps EIF2A, anticorps Eif2a, anticorps eif2a, anticorps eIF2a, anticorps eif2a.S, anticorps eif2A, anticorps eIF-2alpha

Pathways: Ribonucleoprotein Complex Subunit Organization, ER-Nucleus Signaling, Hepatitis C, Methionine Biosynthetic Process, Ribosome Assembly